Trial intelligence / Profile preview

PDD vs PAD to Treat Initially Diagnosed MM

NCT02577783Phase 4Unknown

Sponsor
First Affiliated Hospital of Soochow University
Start
Oct 2015
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Duomeisu in multiple myeloma (MM), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.

02

Drugs

Duomeisu
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT02577783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02577783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call